*Verification required by Program Director

Registration fees include the online course syllabus, continental breakfast and lunch. Physicians can earn ABIM MPC credit without charge (optional). 

The conference syllabus will be available by electronic PDF download. You will receive an email prior to the event that notifies when presentations are available to download. 

REFUNDS: Refunds, minus an administrative fee of $75, will be made only if notice of cancellation is received at uvmcmie@med.uvm.edu prior to April 10, 2026. Refunds are not possible after that date. Substitutions may be possible; please call (802) 656-2292 to inquire.

Pdf Agenda for 2026 Diabetes Conference

7:45 – 8:20am             Registration, Continental Breakfast, and Exhibits 

8:20 – 8:30                   Welcome

                                        Jennifer Kelly, DO, FACE, CCD

                                        Joel Schnure, MD                               

8:30 – 9:30                  Keynote: Diabetes and Bone- A Guide for the Clinician

                                        Harold N. Rosen, MD

9:30 – 10:30                Reducing Cardiovascular Risk in Patients with Diabetes

                                        Kaitlyn Barrett, DO

10:30 – 11:00              Break and Exhibits 

11:00 – 12:00pm        Carb Counting: Past, Present and Future                                                                                                                       Mary L. Spence, RN, CDCES                                                                                                                                   Linda Tilton, RD, CDCES

12:00 – 12:30pm          Unlocking the Potential of a Liver Directed Therapy

                                        Nitin Trivedi, MD

                                            Please join Madrigal for an educational program on potential treatment for                                                       your patients with non-cirrhotic MASH with F2/F3 fibrosis.                                                                                                                                                                                                                                     Product Theater: (NO CREDIT)- Presented by Madrigal Pharmaceuticals

                                       *The presentation for this Product Theater is not designated for CME/CE credit.

                                        Information is solely developed and provided by Madrigal Pharmaceuticals

12:00 – 1:00                Lunch and Exhibits

1:00 – 1:45                  Keynote: New Approaches to Managing Cardio-Kidney-Metabolic Risk in                                                                                               People with Diabetes

                                      Richard E. Pratley, MD                                

1:45 – 2:30                 "Keep Your Friends Close, But Your Enemies Closer"                                                                                                   Management of the Diabetic Foot

                                        Stephen J. Merena, DPM                                                                                                                              

2:30 – 2:45                  Break and Exhibits 

2:45 – 3:30                  From Parallel to Unified: Transforming Care for Obesity and Diabetes

                                        Angela Fitch, MD, FACP, MFOMA

3:30 – 4:15                   GLP1 Agonists for Type 2 Diabetes and Obesity;                                                                                                 Case Based TIPS AND TRICKS for Starting and Maintaining this Class of Drugs

                                        Tina Kader, MD

4:15pm                        Conference Adjourns 

In support of improving patient care, The Robert Larner, M.D. College of Medicine at the University of Vermont is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Vermont designates this live activity for a maximum of 6.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The University of Vermont has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.0 AAPA Category 1 CME credits. Physicians Assistants should claim only the credit commensurate with the extent of their participation. 

This program has been reviewed and is acceptable for up to 6.0 Nursing Contact Hours. 

This course has been approved for up to 6.0 hours of pharmacy continuing education credit. The approval number issued is: UAN JA0000335-0000-26-007-L01-P.

Total Number of Pharmacological Credits available: 1.50 credits. 

This activity was planned by and for the healthcare team, and learners will receive up to 6.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Meeting Disclaimer: Regarding written materials and information received, written or otherwise, during this Conference, the scientific views, statements, and recommendations expressed during this activity represent those of the authors and speakers and do not necessarily represent the views of the University of Vermont. 

Relevant Financial Relationships*

All those with control of content (speakers, planners, moderators, reviewers, staff) who have relevant financial relationships with “ineligible companies” are listed below. (An “ineligible company” is defined as those whose primary business is producing, marketing, selling, reselling or distributing healthcare products used by or on patients.)

Financial Interests to Disclose – Relationships have been Mitigated*:

*Note: All relevant financial relationships, if any were listed above, have been mitigated. All others in control of content have no relevant financial relationships with ineligible companies.